X-Received: by 2002:a05:6000:15c1:b0:218:468b:4c01 with SMTP id y1-20020a05600015c100b00218468b4c01mr10781568wry.60.1655496721290;
Fri, 17 Jun 2022 13:12:01 -0700 (PDT)
X-Received: by 2002:a05:6808:1385:b0:32f:729e:4869 with SMTP id
c5-20020a056808138500b0032f729e4869mr8545720oiw.5.1655496720662; Fri, 17 Jun
2022 13:12:00 -0700 (PDT)
Path: i2pn2.org!i2pn.org!aioe.org!news.mixmin.net!proxad.net!feeder1-2.proxad.net!209.85.128.87.MISMATCH!news-out.google.com!nntp.google.com!postnews.google.com!google-groups.googlegroups.com!not-for-mail
Newsgroups: rec.arts.movies.current-films
Date: Fri, 17 Jun 2022 13:12:00 -0700 (PDT)
Injection-Info: google-groups.googlegroups.com; posting-host=96.47.239.215; posting-account=qNdbKAoAAACIUUzDl5n2IPD8Y4DsKCjb
NNTP-Posting-Host: 96.47.239.215
User-Agent: G2/1.0
MIME-Version: 1.0
Message-ID: <60f094c8-eb43-4572-96d6-ead5dbe6ac27n@googlegroups.com>
Subject: (PDF) Gene Therapy for Neurological Disorders by Fredric P. Manfredsson
From: hesterho...@gmail.com (hester holt)
Injection-Date: Fri, 17 Jun 2022 20:12:01 +0000
Content-Type: text/plain; charset="UTF-8"

X-Received: by 2002:a05:600c:4f47:b0:39c:62cc:75da with SMTP id m7-20020a05600c4f4700b0039c62cc75damr22936835wmq.114.1655505922812;
Fri, 17 Jun 2022 15:45:22 -0700 (PDT)
X-Received: by 2002:a05:6808:207:b0:32e:d7d7:5d9c with SMTP id
l7-20020a056808020700b0032ed7d75d9cmr10982613oie.103.1655505922119; Fri, 17
Jun 2022 15:45:22 -0700 (PDT)
Path: i2pn2.org!i2pn.org!weretis.net!feeder8.news.weretis.net!proxad.net!feeder1-2.proxad.net!209.85.128.88.MISMATCH!news-out.google.com!nntp.google.com!postnews.google.com!google-groups.googlegroups.com!not-for-mail
Newsgroups: rec.arts.movies.current-films
Date: Fri, 17 Jun 2022 15:45:21 -0700 (PDT)
In-Reply-To: <60f094c8-eb43-4572-96d6-ead5dbe6ac27n@googlegroups.com>
Injection-Info: google-groups.googlegroups.com; posting-host=2603:7000:d00:41ac:f427:d5f4:1c:3038;
posting-account=4C3ScwoAAAA2wbWb7EB6D20HjAcd2OwZ
NNTP-Posting-Host: 2603:7000:d00:41ac:f427:d5f4:1c:3038
References: <60f094c8-eb43-4572-96d6-ead5dbe6ac27n@googlegroups.com>
User-Agent: G2/1.0
MIME-Version: 1.0
Message-ID: <e3253d51-3020-47c1-8d1c-85735ecacceen@googlegroups.com>
Subject: Re: (PDF) Gene Therapy for Neurological Disorders by Fredric P. Manfredsson
From: wlahe...@gmail.com (william ahearn)
Injection-Date: Fri, 17 Jun 2022 22:45:22 +0000
Content-Type: text/plain; charset="UTF-8"